ArticleNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2025
Do cardiovascular disease patients return to pre-lockdown sedentary levels? A prospective cohort study.
Article in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Changes in cardiovascular health and physical functioning in non-hospitalized, adult COVID-19 patients after 3 years of follow-up.Physiological reports · 2026Article
- From guidelines to patient-centred action.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe COVID-19 lockdown negatively impacted physical activity (PA) and sedentary behaviour (SB) levels of the Dutch patients with cardiovascular diseases (CVD), but little is known whether these levels returned to pre-pandemic levels. In this study, we evaluated changes in SB and moderate-to-vigorous PA (MVPA) in CVD patients before, during, and after the COVID-19 pandemic and investigated which factors contributed to not returning to pre-pandemic sedentary levels.
methods1,028 Dutch CVD patients participated in this prospective cohort study, where we assessed SB and MVPA before (2018), during (2020), and after (2023) the COVID-19 pandemic using validated questionnaires. Linear mixed model analyses were used to investigate changes over time. Binary logistic regression analyses were performed to examine factors associated with not returning to pre-pandemic SB levels.
resultsSB levels significantly increased from 7.8 h/day at pre-pandemic assessment to 8.7 h/day during lockdown and then significantly decreased to 8.5 h/day at the post-pandemic assessment, but did not return to pre-pandemic levels (p = 0.006). MVPA did not significantly change over time. Lower pre-pandemic SB levels, a larger increase in SB during lockdown, self-reported residual complaints after COVID-19, and diagnosis of arrhythmias at baseline were associated with not returning to pre-pandemic SB levels.
conclusionSedentary time in CVD patients did not return to pre-pandemic levels, 3 years following initial COVID-19 lockdown, while levels of MVPA did not change over time. These findings suggest that lifestyle interventions could be considered to reactivate CVD patients and lower their risk of disease progression and adverse health outcomes. SB bij CVD-patiënten keerde niet terug naar het niveau van voor de pandemie, drie jaar na de eerste COVID-19 lockdown, terwijl MVPA onveranderd bleef. Deze bevindingen suggereren dat leefstijlinterventies overwogen kunnen worden om CVD-patiënten opnieuw te activeren en hun risico op ziekteprogressie en nadelige gezondheidseffecten te verlagen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.